Comparing 0.1% Ropivacaine and 0.0625% Bupivacaine, with fentanyl for labour pain relief

Phase 1

• Conditions: Health Condition 1: 1- Obstetrics

• Registration Number: CTRI/2019/05/019271
• Lead Sponsor: G Ranganaayaki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Parturients requesting epidural analgesia in SMVMCH from May 2019 to September 2020

2. Parturients of ASA physical status 1 and 2

3.Parturients in active labour with cervical dilation of more than 3 cm

4. Full term live fetus without any obstetric complication

Exclusion Criteria

1)Height < 150cm

2)BMI >30

3)Age <18 years

4)Anticipated difficult intubation

5)Contraindications for epidural catheter placement

6)Hyper-sensitivity to study drugs.

7)Administration of IV analgesics within 1hr of epidural request

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain reliefTimepoint: Visual analog scale score will be recorded every 5 min for first 30 min, then at every 30 min till the end of labor. VAS at the end of the first stage and second stage is also noted.

Secondary Outcome Measures

Name	Time	Method
maternal sedation <br/ ><br>sensory blockade <br/ ><br>motor blockadeTimepoint: Maternal sedation will be assessed using modified Ramsay sedation score. Motor block will be assessed by Bromage scale and peak motor block achieved during study is noted. Sensory block will be assessed by loss of cold sensation in midclavicular line, every 30 min and peak sensory level achieved during the study will be noted down. Fetal heart rate will be recorded throughout the study; neonatal welfare will be assessed by Apgar score.